Literature DB >> 27959688

Real-World Evidence - What Is It and What Can It Tell Us?

Rachel E Sherman1, Steven A Anderson1, Gerald J Dal Pan1, Gerry W Gray1, Thomas Gross1, Nina L Hunter1, Lisa LaVange1, Danica Marinac-Dabic1, Peter W Marks1, Melissa A Robb1, Jeffrey Shuren1, Robert Temple1, Janet Woodcock1, Lilly Q Yue1, Robert M Califf1.   

Abstract

Mesh:

Year:  2016        PMID: 27959688     DOI: 10.1056/NEJMsb1609216

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  454 in total

Review 1.  Real-World Evidence for Chronic Lymphocytic Leukemia in the Era of Targeted Therapies.

Authors:  Prioty Islam; Anthony R Mato
Journal:  Cancer J       Date:  2019 Nov/Dec       Impact factor: 3.360

2.  Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.

Authors:  Sean Khozin; Amy P Abernethy; Nathan C Nussbaum; Jizu Zhi; Melissa D Curtis; Melisa Tucker; Shannon E Lee; David E Light; Anala Gossai; Rachael A Sorg; Aracelis Z Torres; Payal Patel; Gideon Michael Blumenthal; Richard Pazdur
Journal:  Oncologist       Date:  2018-01-09

3.  Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.

Authors:  Lisa B Feng; Scott D Grosse; Ridgely Fisk Green; Aliza K Fink; Gregory S Sawicki
Journal:  Health Aff (Millwood)       Date:  2018-05       Impact factor: 6.301

4.  Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.

Authors:  Elisabetta Patorno; Sebastian Schneeweiss; Chandrasekar Gopalakrishnan; David Martin; Jessica M Franklin
Journal:  Diabetes Care       Date:  2019-06-25       Impact factor: 19.112

5.  Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs.

Authors:  Janice Kim; Abhilasha Nair; Patricia Keegan; Julia A Beaver; Paul G Kluetz; Richard Pazdur; Meredith Chuk; Gideon M Blumenthal
Journal:  Oncologist       Date:  2019-12-17

6.  Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.

Authors:  Kelly G Gwathmey; Reza Sadjadi; William B Horton; Mark R Conaway; Carolina Barnett-Tapia; Vera Bril; James W Russell; Aziz Shaibani; Michelle L Mauermann; Michael K Hehir; Noah Kolb; Jeffrey Guptill; Lisa Hobson-Webb; Karissa Gable; Shruti Raja; Nicholas Silvestri; Gil I Wolfe; A Gordon Smith; Rabia Malik; Rebecca Traub; Amruta Joshi; Matthew P Elliott; Sarah Jones; Ted M Burns
Journal:  Neurology       Date:  2018-05-04       Impact factor: 9.910

7.  Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.

Authors:  Mustafa S Ascha; Quinn T Ostrom; James Wright; Priya Kumthekar; Jeremy S Bordeaux; Andrew E Sloan; Fredrick R Schumacher; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05       Impact factor: 4.254

8.  Veridical Causal Inference using Propensity Score Methods for Comparative Effectiveness Research with Medical Claims.

Authors:  Ryan D Ross; Xu Shi; Megan E V Caram; Pheobe A Tsao; Paul Lin; Amy Bohnert; Min Zhang; Bhramar Mukherjee
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-10-20

Review 9.  Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.

Authors:  Gita Thanarajasingam; Lori M Minasian; Frederic Baron; Franco Cavalli; R Angelo De Claro; Amylou C Dueck; Tarec C El-Galaly; Neil Everest; Jan Geissler; Christian Gisselbrecht; John Gribben; Mary Horowitz; S Percy Ivy; Caron A Jacobson; Armand Keating; Paul G Kluetz; Aviva Krauss; Yok Lam Kwong; Richard F Little; Francois-Xavier Mahon; Matthew J Matasar; María-Victoria Mateos; Kristen McCullough; Robert S Miller; Mohamad Mohty; Philippe Moreau; Lindsay M Morton; Sumimasa Nagai; Simon Rule; Jeff Sloan; Pieter Sonneveld; Carrie A Thompson; Kyriaki Tzogani; Flora E van Leeuwen; Galina Velikova; Diego Villa; John R Wingard; Sophie Wintrich; John F Seymour; Thomas M Habermann
Journal:  Lancet Haematol       Date:  2018-06-18       Impact factor: 18.959

10.  Comparison of the cohort selection performance of Australian Medicines Terminology to Anatomical Therapeutic Chemical mappings.

Authors:  Guan N Guo; Jitendra Jonnagaddala; Sanjay Farshid; Vojtech Huser; Christian Reich; Siaw-Teng Liaw
Journal:  J Am Med Inform Assoc       Date:  2019-11-01       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.